| Literature DB >> 27058463 |
Kelly A Edwards1, Sharon F Terry2,3, Dana Gold4, Elizabeth J Horn5, Mary Schwartz6, Molly Stuart7, Suzanne D Vernon8.
Abstract
Biobanks are increasingly powerful tools used in translational research, and disease advocacy organizations (DAOs) are making their presence known as research drivers and partners. We examined DAO approaches to biobanking to inform how the enterprise of biobanking can grow and become even more impactful in human health. In this commentary, we outline overarching approaches from successful DAO biobanks. These lessons learned suggest principles that can create a more participant-centric approach and illustrate the key roles DAOs can play as partners in research initiatives. DAO approaches to biobanking for translational research include the following: be outcome driven; forge alliances that are unexpected-build bridges to enhance translation; come ready for success; be nimble, flexible, and adaptable; and remember that people matter. Each of these principles led to particular practices that have increased the translational impact of biobank collections. The research practices discussed can inform partnerships in all sectors going forward.Entities:
Mesh:
Year: 2016 PMID: 27058463 PMCID: PMC4991568 DOI: 10.1089/bio.2015.0053
Source DB: PubMed Journal: Biopreserv Biobank ISSN: 1947-5543 Impact factor: 2.300